HealthDay News -- Oral antidiabetic (OAD) agents generally result in a maximum 1.5 percent drop in A1C levels, with sulfonylureas and thiazolidinediones having a slightly more beneficial effect than other classes of oral agents, according to research published in the August issue of Diabetes Care.
